<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Critical analysis of the existing evidence indicates that: In patients with documented sustained <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> and/or <z:hpo ids='HP_0001695'>cardiac arrest</z:hpo>, implantable cardioverter defibrillators (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICDs</z:e>) confer a survival benefit </plain></SENT>
<SENT sid="1" pm="."><plain>In several clinical settings this is rather transient, and might be lost when modern medical therapy including β-blockers is implemented </plain></SENT>
<SENT sid="2" pm="."><plain>In patients without sustained <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> or <z:hpo ids='HP_0001695'>cardiac arrest</z:hpo>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICDs</z:e> confer a significant survival benefit only in high-risk patients with ischaemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> and left ventricular ejection fraction of ≤ 35% due to a remote <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Left ventricular ejection fraction alone is rather unlikely to be sufficient for effective <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> risk prediction, due to low sensitivity and specificity </plain></SENT>
<SENT sid="4" pm="."><plain>The benefits of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICDs</z:e> in the elderly as well as in women are not established </plain></SENT>
<SENT sid="5" pm="."><plain>With current prices, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICDs</z:e> are probably cost-effective only when used in high-risk patients without associated comorbidities that limit the life expectancy to &lt;10 years </plain></SENT>
<SENT sid="6" pm="."><plain>Recommendations by current guidelines may result in unnecessary overuse of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> </plain></SENT>
</text></document>